Amyotrophic Lateral Sclerosis Clinical Trials
Amyotrophic Lateral Sclerosis clinical trials study new therapies, devices, and diagnostic tools for amyotrophic Lateral Sclerosis and related neurological symptoms. Corterve gathers actively recruiting Amyotrophic Lateral Sclerosis studies from ClinicalTrials.gov so you can filter them by where you live and whether you may qualify. Neurology trials often include cognitive, imaging, or biomarker assessments. This page is informational only and is not medical advice; discuss participation with your neurologist or physician.
Recruiting Amyotrophic Lateral Sclerosis studies
- Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral SclerosisNCT07023835PHASE2Zydus Therapeutics Inc.La Jolla, California
- ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)NCT04363684Mayo ClinicBirmingham, Alabama
- Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal DementiaNCT03225144National Institute of Neurological Disorders and Stroke (NINDS)Bethesda, Maryland
- ASSESS ALL ALS StudyNCT06578195St. Joseph's Hospital and Medical Center, PhoenixBirmingham, Alabama
- Multicenter ALS Imaging StudyNCT06735014University of MinnesotaGainesville, Florida
- Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALSNCT07322003PHASE3PrileniaPhoenix, Arizona
- PREVENT ALL ALS StudyNCT06581861St. Joseph's Hospital and Medical Center, PhoenixBirmingham, Alabama
- PHENOGENE-1A (Cromolyn) Treatment in Patients With Mild to Moderate ALSNCT07142291PHASE2PhenoNet, Inc.Scottsdale, Arizona
- Spinal Cord Associative Plasticity for ALSNCT06172621NAVA Office of Research and DevelopmentThe Bronx, New York
- Retinal Imaging in Neurodegenerative DiseaseNCT03233646Duke UniversityDurham, North Carolina
- A Study of Ranolazine in ALSNCT06527222PHASE2Swathy Chandrashekhar, MBBSSan Francisco, California
- EIM Via the Myolex mScan as an ALS BiomarkerNCT06491732Beth Israel Deaconess Medical CenterPhoenix, Arizona
See all 66 recruiting Amyotrophic Lateral Sclerosis trials →
Amyotrophic Lateral Sclerosis trials by state
Amyotrophic Lateral Sclerosis trials by metro
Frequently asked questions
- How do I find recruiting Amyotrophic Lateral Sclerosis clinical trials?
- Corterve aggregates actively recruiting Amyotrophic Lateral Sclerosis studies from the public ClinicalTrials.gov registry. Browse the studies listed on this page or take a free health assessment to see trials you may qualify for based on your profile.
- Are Amyotrophic Lateral Sclerosis clinical trials free to join?
- Study participation is typically free — research sponsors cover the cost of the investigational treatment and study-related visits. Many trials also compensate participants for time and travel. Details vary by study.
- Who can take part in a Amyotrophic Lateral Sclerosis clinical trial?
- Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.